{"text_format":"3","workbook":"xls","n_sheets":1,"sheets":["Sheet3"],"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"Sheet3","index":0,"n_rows":17,"n_cols":11,"rows_kept":17,"merged":[[0,0,0,10]],"flags":["formulas_cached_only"]}
["Table 1.Review of literature."]
["Case","Study","Sex/Age","Obstructive Hydrocephalus","MRI/CT","Presenting Complaint ","Treatment","Immunohistochemistry","Ki-67","Postoperative diagnosis","Follow-up"]
[1,"Warmuth-Metz et al6  (1999)","M/17","Yes","Tl: isointense; T2: slighly hyperintense;Enhancement: intensity and homogeneons;CT:calcification","Headache,ataxia and neck pain","PR(first);STR(second);RT","Pos:Syn,NF;Neg:GFAP ",">2%(first)","Atypical","4m"]
[2,"Hsu et al7  (2002)","F/35","Yes","T1:hypointense; T2: hyperintense;Ehancement: markedly heteogeneous enlhancement with multiple cystic chanees","Headache and blurred vision","GTR","Pos:Syn,NSE;Neg:GFAP ","NA","Atypical","NA"]
[3,"Cook et al8  (2004)","F/58","NO","Enhancement: heterogeneous enhancement;CT:calcification","Headache, nausea, nystagmus, impaired gait","STR+RT","Pos:NSE;Neg:NF,Syn,GFAP ","1%-2%","Typical","4m"]
[4,"Cultrera et al9 (2005)","M/28","NO","Enhancement:homogeneous enhancement","Diptopia and gait instability","GTR","Pos:Syn;Neg:GFAP ",{"v":0.06,"d":"6%"},"Atypical","NA"]
[5,"Gallina et al0 (2005)","F/68","Yes","Enhancemet:slightlty enhancing;CT:calcification,hemorhage,","Headache, nausea and vomiting ","GTR,EVD,VPS","Pos:NSE,Syn;Neg:NA",{"v":0.01,"d":"1%"},"Typical","NA"]
[6,"Li et al11 (2009)","M/27","Yes","Tl: inhomogeneous hypointens; T2: inhomogereous hyperintense; Enhancement:inhomogeneous mild to moderate enhancement","Dizziness and vomiting","NA","Pos:Syn,NenN,EMA;Neg:GFAP,Olig-2;Nestin,Leu-7 ",{"v":0.08,"d":"8%"},"Atypical","NA"]
[7,"Gao et al12 (2011)","F/34","NO","Tl: isointense; T2: slightlty hyperintense;Enhancement: inhomogeneous","Dizziness, nausea and vomiting","STR+RT","Pos:Syn,NSE;Neg:GFAP,S-100 ","NA","Typical","2m"]
[8,"You et al13 (2011)","F/59","Yes","Tl: hypointense; T2: hyperintense; Enhancement: inhomogeneous","Headache, nausea and vomiting and weakness of 1ower 1imbs ","GTR","Pos:GFAP,NSE,Syn,S-100,Vim ","NA","Typical","NA"]
[9,"You et al13 (2011)","F/41","Yes","Tl: iso-and hypointense; T2: hyper- and hypointense;Enhancement: inhomogeneous obvious enhancement","Headache, nausea and vomiting,","GTR","NA","NA","Typical","NA"]
[10,"Jain et al14 (2012)","M/7","NO","Tl: hypointense; T2: hyperintense;Enhancement: obvious enhancement with cysticchanges;CT:hemomhage","Headache and vomiting","GTR","Pos:NenN,Syn;Neg:EMA ,GFAP,S-100,CD68,leukocyte common antigen","10%-20%","Atypical","8m"]
[11,"Zhang et al15(2017)","M/16","NO","Tl: iso-and hypointens; T2: slightly hyperintense; Enhancement: mild enhancement","Headache and dizziness","GTR","Pos:S-100,GFAP,NSE,NeuN,BCl-2;Neg:AE1/AE3,Vim,Oligo-2,Nestin,NF,EMA,P53,CD99","5%-30%","Typical","6m"]
[12,"Cao et al16 (2017)","F/30","Yes","Cystic and solid","Headache, dizziness ,nausea and vomiting","NA","Pos:Syn,S-100,GFAP","<3%","Typical","NA"]
[13,"Richardson et al17 (2019)","F/70","Yes","Enthancement: heterogeneous enhancement","Vomiting,vertigo, and altared taste","STR,EVD","Pos:NenN,NF,Syn;Neg:GFAP","5%-7%","Atypical","9m"]
[14,"Tang et al18  (2019)","M/31","Yes","Entirely cystic","Tinnitus.amaurosis and weakness of lower 1imbs","NA","Pos:S100(+),Olig-2(+),Syn(+);Neg:GFAP(-),P53(-),E GFR(-),Vim(-),I DH-1(-),MGMT(-)",{"v":0.05,"d":"5%"},"Typical","NA"]
[15,"Present case  (2021)","F/44","Yes","T1:mixed hypointense ;T2:mixed hyperintense;Enhancement:mild progressive and inheterogeneous enhancement","Headache, dizziness and gait instability","GTR","Pos:Nstin,Syn,MAP2,Calretinin;Neg:NF,GFAP","About 10%","Typical","36m"]